In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: Glucosidation as the principal metabolic route

Drug Metabolism and Disposition

Volumn 29, Issue 3, 2001, Pages 326-334

  Chmela, Z ^a   Vesely J ^a   Lemr, K ^a   Rypka, M ^a   Hanus J ^a   Havlicek L ^a   Krystof V ^a   Michnova L ^a   Fuksova K ^a   Lukes J ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BOHEMINE; CYCLIN DEPENDENT KINASE INHIBITOR; TRITIUM; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE; URIDINE DIPHOSPHATE XYLOSE;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; DRUG CONJUGATION; DRUG EXCRETION; DRUG METABOLISM; DRUG STRUCTURE; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; TRITIUM;

EID: 0035115178     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. The dismutation of formaldehyde by liver alcohol dehydrogenase
2. Purification and molecular properties of mouse alcohol dehydrogenase isozymes
3. Biotransformation of cerivastatin in mice, rats, and dogs in vivo
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors
6. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development
7. A study of the kinetics and mechanism of yeast alcohol dehydrogenase with a variety of substrates
8. Subcellular localization of the F1 and F2 isozymes of horse liver aldehyde dehydrogenase
9. Comparison of three classes of human liver alcohol dehydrogenase. Emphasis on different substrate binding pockets
10. Studies of mammalian glucoside conjugation
11. ATP-site directed inhibitors of cyclin-dependent kinases
12. Exploiring chemical libraries, structure, and genomics in the search for kinase inhibitors
13. Cytokinin-derived cyclin-dependent kinase inhibitors: Synthesis and cdc2 inhibitory activity of olomoucine and related compounds
14. Aldehyde dehydrogenase from human liver. Primary structure of the cytoplasmic isoenzyme
15. Horse-liver alcohol dehydrogenase-catalyzed oxidation of aldehydes: Dismutation precedes net production of reduced nicotinamide adenine dinucleotide
16. Understanding and controlling the cell cycle with natural products
17. 2,6,9-Trisubstituted purines: Highly potent and selective CDK1 inhibitors
18. Nomenclature of alcohol dehydrogenases
19. Metabolic fate of indeloxazine hydrochloride: α-Glucoside formation in rats
20. Oxidation of 3-butene-1,2-diol by alcohol dehydrogenase
21. The effect of disulfiram on the aldehyde dehydrogenases of sheep liver
22. N-Acetylglucosaminides: A new type of bile acid conjugate in man
23. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for selective conjugation reaction of 7β-hydroxylated bile acids in humans
24. Isolation and characterization of UDP-glucose dolichyl-phosphate glucosyltransferase from human liver
25. Formation of bile acid glucosides by sugar nucleotide-independent glucosyltransferase isolated from human liver microsomes
26. Properties and potential-applications of chemical inhibitors of cyclin-dependent kinases
27. Hopantenic acid β-glucoside as a new urinary metabolite of calcium hopantenate in dogs
28. The β-glucosidation and β-glucuronidation of pantothenic acid compared with p-nitrophenol in dog liver microsomes
29. A novel UDP-Glc-specific glucuronyltransferase catalyzing the biosynthesis of 6-O-glucosides of bile acids in human liver microsomes
30. Enzymology of ethanol and acetaldehyde metabolism in mammals
31. Synthesis and activity of 2,6,9-trisubstituted purines
32. Multiple modes of ligand recognition: Crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine
33. Cyclin-dependent kinase inhibitors: Useful targets in cell cycle regulation
34. Olomoucine-derived synthetic cdk inhibitors: Development and analysis of new compounds
35. Aldehyde dismutase activity of human liver alcohol dehydrogenase
36. Drug glucosidation
37. Inhibition of cyclin-dependent kinases by purine analogues
38. Small-molecule inhibitors of cyclin-dependent kinases: Molecular tools and potential therapeutics